Metropolitan Life Insurance CO Prometheus Biosciences, Inc. Transaction History

Metropolitan Life Insurance CO

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$103.46 - $126.29 $28,451 - $34,729	-275 Reduced 12.73%	1,885 $202,000
Q4 2022 Jun 14, 2023	BUY	$36.06 - $117.21 $9,916 - $32,232	275 Added 14.59%	2,160 $238 Million
Q4 2022 Mar 30, 2023	BUY	$36.06 - $117.21 $13,270 - $43,133	368 Added 20.54%	2,160 $237,000
Q4 2022 Feb 15, 2023	BUY	$36.06 - $117.21 $13,270 - $43,133	368 Added 20.54%	2,160 $237,000
Q3 2022 Jun 14, 2023	SELL	$28.17 - $59.01 $2,619 - $5,487	-93 Reduced 4.93%	1,792 $106 Million
Q2 2022 Jun 20, 2023	SELL	$22.39 - $38.94 $2,082 - $3,621	-93 Reduced 4.93%	1,792 $50,000
Q1 2022 Jun 20, 2023	SELL	$30.13 - $50.0 $2,802 - $4,650	-93 Reduced 4.93%	1,792 $67,000
Q1 2022 Mar 30, 2023	SELL	$30.13 - $50.0 $196,809 - $326,600	-6,532 Reduced 78.47%	1,792 $67,000
Q1 2022 May 12, 2022	SELL	$30.13 - $50.0 $196,809 - $326,600	-6,532 Reduced 78.47%	1,792 $68,000
Q4 2021 Jun 21, 2023	BUY	$22.28 - $39.54 $143,460 - $254,598	6,439 Added 341.59%	8,324 $329,000
Q4 2021 Mar 30, 2023	BUY	$22.28 - $39.54 $102,688 - $182,239	4,609 Added 124.06%	8,324 $329,000
Q4 2021 Feb 15, 2022	BUY	$22.28 - $39.54 $102,688 - $182,239	4,609 Added 124.06%	8,324 $329,000
Q3 2021 Jun 21, 2023	BUY	$20.89 - $26.96 $38,228 - $49,336	1,830 Added 97.08%	3,715 $88,000
Q3 2021 Mar 30, 2023	BUY	$20.89 - $26.96 $32,483 - $41,922	1,555 Added 71.99%	3,715 $88,000
Q3 2021 Nov 15, 2021	BUY	$20.89 - $26.96 $77,606 - $100,156	3,715 New	3,715 $88,000

29.6K

Ticker RXDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,904,100
Description
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.